Brad Hively - Nov 13, 2023 Form 4 Insider Report for Oncology Institute, Inc. (TOI)

Role
Director
Signature
/s/ Mark Hueppelsheuser, Attorney-in-Fact for Brad Hively
Stock symbol
TOI
Transactions as of
Nov 13, 2023
Transactions value $
-$143,386
Form type
4
Date filed
11/15/2023, 06:49 PM
Previous filing
Mar 21, 2023
Next filing
Nov 21, 2023

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction TOI Common stock Options Exercise $40K +47K +6.49% $0.85 771K Nov 13, 2023 Direct
transaction TOI Common stock Sale -$119K -47K -6.09% $2.52 724K Nov 13, 2023 Direct
transaction TOI Common stock Disposed to Issuer -$64.8K -27.1K -3.74% $2.39 697K Nov 14, 2023 Direct

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction TOI Non-Qualified Stock Option (right to buy) Options Exercise $0 -47K -2.59% $0.00 1.77M Nov 13, 2023 Common stock 47K $0.85 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 These options vest as to 1/4th of the total number of shares subject to the option on the first anniversary of December 2, 2019 (the "Original Grant Date"), and as to 1/36th of the total number of shares monthly thereafter, such that 100% of the shares subject to the option will be fully vested on the fourth anniversary of the Original Grant Date, subject to continued employment through the vest date.